Treatment you can take at home
FOR ADULT PATIENTS. It is not known if ONUREG® is safe and effective in children under 18 years of age.
FOR ADULT PATIENTS. It is not known if ONUREG® is safe and effective in children under 18 years of age.

ONUREG® is the first FDA-approved continued treatment for people with AML who are in first remission

ONUREG® is a prescription medicine used for continued treatment of adults with acute myeloid leukemia (AML) who:

  • had a first complete remission (CR) following intensive induction chemotherapy with or without recovery of your blood cell counts, and
  • who are not able to complete intensive curative therapy.

It is not known if ONUREG® is safe and effective in children under 18 years of age.